Exelixis
EXEL
#1571
Rank
$13.99 B
Marketcap
$55.68
Share price
0.23%
Change (1 day)
24.26%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company